Zobrazeno 1 - 10
of 205
pro vyhledávání: '"Moritaka SUGA"'
Autor:
Kazuya Ichikado, Hidenori Ichiyasu, Kazuhiro Iyonaga, Kodai Kawamura, Noritaka Higashi, Takeshi Johkoh, Kiminori Fujimoto, Jun Morinaga, Minoru Yoshida, Katsuhiko Mitsuzaki, Moritaka Suga, Naoya Tanabe, Tomohiro Handa, Toyohiro Hirai, Takuro Sakagami
Publikováno v:
BMC Pulmonary Medicine, Vol 23, Iss 1, Pp 1-7 (2023)
Abstract Background Interstitial lung abnormalities (ILAs) are subtle or mild parenchymal abnormalities observed in more than 5% of the lungs on computed tomography (CT) scans in patients in whom interstitial lung disease was not previously clinicall
Externí odkaz:
https://doaj.org/article/f9e0f2886d88481f82a9700e9df37781
Autor:
Kenta Nishiyama, Kazuya Ichikado, Keisuke Anan, Kazunori Nakamura, Kodai Kawamura, Moritaka Suga, Takuro Sakagami
Publikováno v:
PLoS ONE, Vol 18, Iss 2, p e0282241 (2023)
BackgroundThere is no existing reliable and practical method for predicting the prognosis of acute respiratory distress syndrome (ARDS).ObjectiveWe aimed to clarify the association between the ROX index, which is calculated as the ratio of peripheral
Externí odkaz:
https://doaj.org/article/3924aa2b8d1c47068c61db7e44c757ea
Autor:
Kazuya Ichikado, Kodai Kawamura, Takeshi Johkoh, Kiminori Fujimoto, Ayumi Shintani, Satoru Hashimoto, Yoshitomo Eguchi, Yuko Yasuda, Keisuke Anan, Naoki Shingu, Yoshihiko Sakata, Junpei Hisanaga, Tatsuya Nitawaki, Miwa Iio, Yuko Sekido, Kenta Nishiyama, Kazunori Nakamura, Moritaka Suga, Hidenori Ichiyasu, Takuro Sakagami
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract There have been no report of objective clinical characteristics or prognostic factors that predict fatal outcome of acute respiratory distress syndrome (ARDS) since the Berlin definition was published. The aim of this study is to identify cl
Externí odkaz:
https://doaj.org/article/10a0ad4de40c4551b2289602c8b90777
Autor:
Kimiyuki Ikeda, Hirofumi Chiba, Hirotaka Nishikiori, Arata Azuma, Yasuhiro Kondoh, Takashi Ogura, Yoshio Taguchi, Masahito Ebina, Hiroki Sakaguchi, Shogo Miyazawa, Moritaka Suga, Yukihiko Sugiyama, Toshihiro Nukiwa, Shoji Kudoh, Hiroki Takahashi, Pirfenidone Clinical Study Group in Japan
Publikováno v:
Respiratory Research, Vol 21, Iss 1, Pp 1-12 (2020)
Abstract Background Idiopathic pulmonary fibrosis (IPF) is a progressive, fatal disorder with a variable disease course. The recent advancement of antifibrotic therapy has increased the need for reliable and specific biomarkers. This study aimed to a
Externí odkaz:
https://doaj.org/article/b54bb130f11547e4a7e9aad2c5862ed8
Autor:
Kodai Kawamura, Kazuya Ichikado, Hidenori Ichiyasu, Keisuke Anan, Yuko Yasuda, Moritaka Suga, Takuro Sakagami
Publikováno v:
BMC Pulmonary Medicine, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background and objective Here, we present real-world data on the incidence and risk factors of acute exacerbation (AE) in patients with chronic fibrotic interstitial pneumonia (CFIP) treated with antifibrotic agents, which has been previousl
Externí odkaz:
https://doaj.org/article/aa576b3312d74fd0a6d4829d794686e7
Publikováno v:
BMC Pulmonary Medicine, Vol 17, Iss 1, Pp 1-8 (2017)
Abstract Background Acute exacerbation (AE) of idiopathic pulmonary fibrosis (IPF) is a fatal condition without an established pharmaceutical treatment. Most patients are treated with high-dose corticosteroids and broad-spectrum antibiotics. Azithrom
Externí odkaz:
https://doaj.org/article/c0cab4dd5830468f8e3542114790f864
Publikováno v:
Critical Care, Vol 21, Iss 1, Pp 1-7 (2017)
Abstract Background The efficacy of corticosteroid use in acute respiratory distress syndrome (ARDS) remains controversial. Generally, short-term high-dose corticosteroid therapy is considered to be ineffective in ARDS. On the other hand, low-dose, l
Externí odkaz:
https://doaj.org/article/aaccf85a921c49a89dab84ab8d9d00c5
Autor:
Masatsugu Nozoe, MD, PhD, Toshihiro Honda, MD, PhD, Mitsuko Honda, MD, PhD, Kazuya Ichikado, MD, PhD, Moritaka Suga, MD, PhD, Koichi Nakao, MD, PhD
Publikováno v:
Journal of Arrhythmia, Vol 29, Iss 1, Pp 5-8 (2013)
Background: Amiodarone is a useful antiarrhythmic drug, especially in patients with serious heart diseases, but amiodarone-induced interstitial pneumonia (AMD-IP) is sometimes lethal. Methods and results: We retrospectively analyzed the clinical char
Externí odkaz:
https://doaj.org/article/d46e01a768854bb2965c0d2c09d6c356
Autor:
Kazuya Ichikado, Hidenori Ichiyasu, Kazuhiro Iyonaga, Kodai Kawamura, Noritaka Higashi, Takeshi Johkoh, Kiminori Fujimoto, Jun Morinaga, Minoru Yoshida, Katsuhiko Mitsuzaki, Moritaka Suga, Naoya Tanabe, Tomohiro Handa, Toyohiro Hirai, Takuro Sakagami
IntroductionInterstitial lung abnormalities (ILAs) are subtle or mild parenchymal abnormalities observed in more than 5 % of the lungs on CT scans in patients in whom interstitial lung disease was not previously clinically suspected and is considered
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::82cea675bbf8df05b466f03e1aa367e7
https://doi.org/10.1101/2023.01.04.23284128
https://doi.org/10.1101/2023.01.04.23284128
Autor:
Hiroki Takahashi, Moritaka Suga, Toshihiro Nukiwa, Shoji Kudoh, Masahito Ebina, Yasuhiro Kondoh, Shogo Miyazawa, Koji Sakamoto, Hiroki Sakaguchi, Takashi Ogura, Atsushi Suzuki, Yukihiko Sugiyama, Yoshio Taguchi, Arata Azuma
Publikováno v:
Chest. 160:1372-1376